2009 Artery Explorer Tour Kicks Off This Month, Urging People Across the Country to Take Action Against Atherosclerosis WILMINGTON, Del., March...
2009 Artery Explorer Tour Kicks Off This Month, Urging People Across the Country to Take Action Against Atherosclerosis WILMINGTON, Del., March 24...
SYMBICORT provides a new, fast-acting(1) combination treatment option for millions of Americans with debilitating lung disease WILMINGTON, Del...
SEROQUEL XR is Now Approved to Treat the Depressive, Manic, and Mixed Episodes of Bipolar Disorder WILMINGTON, Del., Feb. 23...
Patients filled 2.7 million prescriptions through AZ&Me(TM) Prescription Savings Programs WILMINGTON, Del., Feb. 10 /PRNewswire-FirstCall/...
Agreement includes research collaboration to generate follow-up TRI compounds WILMINGTON, Del., Feb. 9 /PRNewswire-FirstCall/ -- AstraZeneca...
-Filing also includes age appropriate formulation of 2.5 mg and 5 mg strengths of NEXIUM for Delayed-Release Oral Suspension- WILMINGTON, Del...
WILMINGTON, Del., Nov. 25 /PRNewswire-FirstCall/ -- AstraZeneca today announced it has entered into a settlement agreement in its Pulmicort...
Data also found SYMBICORT opened airways in less than 15 minutes WILMINGTON, Del., Oct. 29 /PRNewswire-FirstCall/ -- Data presented today from...
WILMINGTON, Del., Sept. 23 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the US District Court for the District of New Jersey has...
WILMINGTON, Del., Sept. 22 /PRNewswire-FirstCall/ -- AstraZeneca today announced that the United States Food and Drug Administration (FDA) has...
WILMINGTON, Del., Sept. 10 /PRNewswire-FirstCall/ -- Newly released results from two previously published studies demonstrated patients...
VANCOUVER, BRITISH COLUMBIA--(Marketwire - Aug. 22, 2008) - 08/08/22 - TSX Venture Exchange Daily Bulletins TSX VENTURE COMPANIES ABBASTAR...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.